10x Genomics, Inc.

TXG· NASDAQ· Health Care· Health Care Equipment & Services

$47.01-0.55%

2026-08-03

Financials

Valuation Metrics

10x Genomics, Inc.'s Market Cap is $5.97B. At end of 2025 it was $2.07B. Ranked #1265 of 3,112 in US market (top 41%), #421 of 1,445 on NASDAQ (top 29%), #80 of 206 in Health Care Equipment & Services (top 39%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$5.97B	US#1,265/3,112 Sec#80/206
Revenue	$639M	US#2,221/3,112 Sec#137/206
Net Income	$-23M	US—/3,112 Sec—/206
Total Assets	$1.02B	US#2,442/3,112 Sec#128/206
Net Assets	$814M	US#1,912/3,112 Sec#100/206
Value
P/B	7.33x	US#2,443/3,112 Sec#159/206
P/S	9.34x	US#2,631/3,112 Sec#184/206
EV/EBITDA	59.59x	US#2,381/3,112 Sec#126/206
FCF Yield	2.05%	US#1,947/3,112 Sec#123/206
Profitability
ROE	-2.78%	US#2,256/3,112 Sec#121/206
ROA	-2.23%	US#2,391/3,112 Sec#128/206
Op. Margin	-6.06%	US#2,582/3,112 Sec#151/206
Revenue Growth	-2.61%	US#2,406/3,112 Sec#178/206
Financial Health
Debt Ratio	24.74%	US#269/3,112 Sec#28/206
Total Debt	$81M	US#2,431/3,112 Sec#140/206
FCF	$122M	US#1,585/3,112 Sec#97/206
Cash	$490M	US#1,082/3,112 Sec#62/206
Current Ratio	5.90x	US#408/3,112 Sec#30/206
Net Debt/EBITDA	-4.38x	US#80/3,112 Sec#8/206
Performance
1Y Return	259.40%	US#74/3,112 Sec#5/206
1M Return	20.51%	US#135/3,112 Sec#20/206
From 52W High	-6.62%	US#723/3,112 Sec#49/206
1Y MDD	-28.03%	US#1,245/3,112 Sec#41/206
Trading
Volume	3,372,140 shares	US#562/3,112 Sec#30/206
Trading Value	$158M	US#630/3,112 Sec#49/206
Per Share
EPS	$-0.34	US—/3,112 Sec—/206
BPS	$6.27	US#2,101/3,112 Sec#133/206